Protalix BioTherapeutics (PLX) Reports Q1 Loss of $0.05
Tweet
Share
E-mailGet Alerts PLX Hot Sheet
Price: $2.84 +3.27%
Revenue Growth %: -33.6%
Financial Fact:
NET LOSS FOR THE PERIOD: -7.29M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Revenue Growth %: -33.6%
Financial Fact:
NET LOSS FOR THE PERIOD: -7.29M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Protalix BioTherapeutics (NYSE: PLX) reported Q1 EPS of ($0.05). Revenue for the quarter came in at $16.1 million versus the consensus estimate of $15.5 million.
For earnings history and earnings-related data on Protalix BioTherapeutics (PLX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- KB Home (KBH) Tops Q3 EPS by 16c
- Thor Industries (THO) Misses Q4 EPS by 13c
- AnaptysBio, Inc. (ANAB) Tops Q2 EPS by 524c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
